...
首页> 外文期刊>Vox Sanguinis: International Journal of Blood Transfusion and Immunohaematology >De novo protein synthesis in mature platelets: a consideration for transfusion medicine.
【24h】

De novo protein synthesis in mature platelets: a consideration for transfusion medicine.

机译:新创成熟血小板的蛋白质合成:一个考虑输血医学。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Platelet function in thrombosis and haemostasis is reasonably well understood at the molecular level with respect to the proteins involved in cellular structure, signalling networks and platelet interaction with clotting factors and other cells. However, the natural history of these proteins has only recently garnered the attention of platelet researchers. De novo protein synthesis in platelets was discovered 40 years ago; however, it was generally dismissed as merely an interesting minor phenomenon until studies over the past few years renewed interest in this aspect of platelet proteins. It is now accepted that anucleate platelets not only have the potential to synthesize proteins, but this capacity seems to be required to fulfil their function. With translational control as the primary mode of regulation, platelets are able to express biologically relevant gene products in a timely and signal-dependent manner. Platelet protein synthesis during storage of platelet concentrates is a nascent area of research. Protein synthesis does occur, although not for all proteins found in the platelet protein profile. Furthermore, mRNA appears to be well preserved under standard storage conditions. Although its significance is not yet understood, the ability to replace proteins may form a type of cellular repair mechanism during storage. Disruption by inappropriate storage conditions or processes that block protein synthesis such as pathogen reduction technologies may have direct effects on the ability of platelets to synthesize proteins during storage.
机译:血小板血栓和止血作用在分子水平上很容易理解对参与细胞的蛋白质结构,信号网络和血小板与凝血因子和其他交互细胞。蛋白质最近才得到关注血小板的研究人员。合成在血小板被发现40年前;之前只是一个有趣的小现象研究在过去的几年里重新燃起的兴趣在这方面的血小板蛋白。无核血小板不仅接受了合成蛋白质的潜力,但这似乎被要求履行能力函数。监管的主要模式,血小板就可以表达生物相关基因产物及时的和相互依赖的方式。蛋白质合成过程中存储的血小板集中是一个新兴的研究领域。蛋白质合成,尽管不是蛋白质中发现血小板蛋白概要文件。在标准的存储条件下保存。尽管它的重要性还没有理解,取代蛋白可以形成一个类型的能力在存储的细胞修复机制。不适当的储存条件或中断过程,阻止蛋白质合成等病原体可能直接还原技术对血小板的合成能力的影响蛋白质在存储。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号